| 000 | 01735 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511223914.0 | ||
| 264 | 0 | _c19900416 | |
| 008 | 199004s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19900401)65:7<1478::aid-cncr2820650705>3.0.co;2-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeydel, H G | |
| 245 | 0 | 0 |
_aHyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience. _h[electronic resource] |
| 260 |
_bCancer _cApr 1990 |
||
| 300 |
_a1478-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMitomycin |
| 650 | 0 | 4 |
_aMitomycins _xadministration & dosage |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmortality |
| 650 | 0 | 4 |
_aRadiation Injuries _xepidemiology |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aStreptozocin _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aStablein, D M | |
| 700 | 1 | _aLeichman, L P | |
| 700 | 1 | _aKinzie, J J | |
| 700 | 1 | _aThomas, P R | |
| 773 | 0 |
_tCancer _gvol. 65 _gno. 7 _gp. 1478-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19900401)65:7<1478::aid-cncr2820650705>3.0.co;2-3 _zAvailable from publisher's website |
| 999 |
_c2144203 _d2144203 |
||